Medical Care Technologies Inc (MDCE)

[Decarz]

Got this E-mail thus morning

MDCE Participates in E-Health Partnership with Hong Kong Hospital

 Good Morning!
 
 The disastrous start to Obamacare proved how important it is to have solid technology behind any major e-health effort. It's time to put all of this together with a SUBPENNY alert.

 
As you may know my subpenny alerts are well known for frequently soaring in price appreciation within minutes of the stock market open. Don't blink because you could miss one of my subpenny firework shows!


MDCE is in the business of providing those solutions to major health authorities and has expansive operations in Asia – especially in China.


The Chinese healthcare sector was worth more than $357 billion in 2011 and growth is expected to push that figure to $1 trillion by 2020.

MDCE is now a participant in the Hong Kong Hospital Authority PPI-ePR Public Private Partnership (PPP) program, where the company is expected to aggressively roll out its medical care technologies.

The development means now that MDCE is no longer a play to be taken for granted. Its position as a bottom bounce play is already causing quite a stir. The last session saw a doubling in valuation and MDCE closed up 100%.

MDCE has a very healthy volume profile too and average volume is well past the 20 million share mark.


This is the perfect short term bounce opportunity and I want you to take maximum advantage of it.

Start your research ASAP.

Investor Highlights

MDCE moved one step closer to rolling out is medical care technologies after it signed up to participate in the Hong Kong Hospital Authority PPI-ePR Public Private Partnership (PPP) program.


MDCE’s presence in the Chinese healthcare sector is a massive reason the company’s growth potential is strong. Chinese healthcare is now worth more than $357 billion.


MDCE is very well positioned as a bottom bounce play. Market valuation is steep in triple-zero territory.


MDCE has seen very robust interest from traders. In the last few weeks volume has been growing consistently and a breakout resulted in more than 271 million shares changing hands.

The explosion in volume has translated well for price movements. MDCE closed up 100% in its last trading session.

MDCE’s upside potential is predicated on a strong RSI of 39, a position that echoes the play’s bounce potential from current levels.

About MDCE

MDCE Medical Care Technologies Inc., develops e-Health information technology solutions and services and a network of integrated healthcare family and children’s clinics in urban areas throughout China.


MDCE sells and distributes pharmaceutical and nutraceutical products, and other merchandise, including over-the-counter medicines, herbal products, personal care products, and family care products.


MDCE serves retail pharmacies, pharmaceutical companies, hospitals, physicians’ office practices, and consumers; and industrial and food microbiology laboratories.


MDCE was founded in 2007 and is headquartered in Beijing, China.


Chinese Healthcare Continues Northward Climb

China’s health-care sector continues to develop at an astonishing rate: spending is projected to grow from $357 billion in 2011 to $1 trillion in 2020. From pharmaceuticals to medical products to consumer health, China remains among the world’s most attractive markets, and by far the fastest-growing of all the large emerging ones.


It is not surprising that multinationals are flocking to take advantage of the opportunities, but long-term success is by no means assured. Although we remain optimistic about the overall outlook for China’s health-care market, multinationals will find it harder to compete. We expect a clearer separation between winners and laggards. Late entrants may struggle.

Three themes will shape China’s health-care market: the continuation of economic and demographic trends, further health-care reform, and the policies articulated in the government’s 12th five-year plan. Some of these forces—such as improvements in infrastructure, the broadening of insurance coverage, and significant support for innovation—will have positive implications for multinational companies.

Others—for example, pressure on pricing and the rise of local champions—will have negative implications. In certain respects (including the bid to reconcile low-cost universal health-care coverage with rewards for innovation) the forces come into direct opposition. To paraphrase Vice Premier Li Keqiang, reform of the country’s health-care system has entered “uncharted waters.”


The forces behind the boom in China’s health-care market


Health-care companies have celebrated China’s robust market in recent years; it’s a bright spot compared with the lackluster conditions they contend with in many other countries.

What a difference just a few years can make. Strong growth in the health-care sector is fueled by favorable demographic trends, continuing urbanization, an increasing disease burden, the overall economy’s healthy expansion, and income growth (which encourages greater awareness of and access to treatments).


It also reflects the government’s focus on health care as both a social priority (as seen in a 2009 health-care reform) and a strategic one (in the 12th five-year plan’s impact on the biomedical industry). Health-care expenditures have more than doubled—from $156 billion in 2006 to $357 billion in 2011—inching closer to 5 percent of the country’s GDP. From pharmaceuticals to medical devices to traditional Chinese medicine, almost every health sector has benefited

Recent Developments

Medical Care Technologies Inc. to Participate in an E-Health Public Private Partnership (PPP) Program of the Hospital Authority in Hong Kong

HONG KONG, CHINA--(Marketwired - Apr 22, 2014) - Medical Care Technologies Inc. (OTC Pink: MDCE) (PINKSHEETS: MDCE), a healthcare technology company providing information technology solutions and family healthcare services in China, today announced that it will be participating in the Hong Kong Hospital Authority PPI-ePR Public Private Partnership (PPP) program.


Public Private Interface - Electronic Patient Record sharing Pilot Project (PPI-ePR) is the first step towards the goal of developing a territory-wide electronic Health Record (eHR) system according to the Hospital Authority in Hong Kong. The growing popularity of web technology has created a new window of opportunity for information communication, dissemination and assimilation. The PPI-ePR Project implemented a web-based electronic system to allow integrated, real-time patient-based information to be shared among clinics, private and public hospitals.

"The Hospital Authority in Hong Kong has long valued its collaboration with the private sector in expanding healthcare service and choices for our patients," commenting Dr. W L Cheung, the Director of Cluster Services Division, Hospital Authority. "In recent years, leveraging on available capacity and capability in the private sector through Public Private Partnerships (PPP) has become a key strategy for managing demands for and enhancing public patients' access to clinical services."

"Participating in the Hong Kong Hospital Authority PPI-ePR Public Private Partnership is an important first step in our preparation towards the pilot roll-out of Medical Care Technologies' e-Health Information Technology solutions in Hong Kong," said James Lau, Chief Executive Officer of Medical Care Technologies Inc. "We are very pleased to have the proactive support and cooperation from the Hospital Authority in Hong Kong."


Triple-zero and very heavy volume is a very potent combination and a major catalyst for another big breakout in price.


Don’t let MDCE make its next big move without you.


To learn more about MDCE please visit their website: http://www.medicaretechinc.com/

Regards,
PREPUMP STOCKS
 
DISCLAIMER:
 
The content of this e-mail is paid advertising not a recommendation nor an offer to buy or sell securities.  We are an information and marketing firm not a financial analyst, investment advisor or broker/dealer. We are in the business of marketing and advertising companies to generate exposure of them by sending alerts to our subscribers for monetary compensation and we have been compensated fifteen thousand USD for this report by an unaffiliated third party. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only.
 
Anyone viewing this newsletter should assume the hiring party or affiliates of the hiring party own shares of the company mentioned which they plan to liquidate, further understanding that the liquidation of those shares may or may not negatively impact the share price.
 
Investing in securities is highly speculative and carries a great deal of risk. You may lose your entire investment. If you cannot afford to lose your entire investment do NOT invest in securities.  Frequently, companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur.
 
We will never own or beneficially own any securities of any company mentioned in this email. We are advertisers, not investors or traders.
 
This report is based entirely upon information gathered from public information and third party websites. Although the information contained in this e-mail is believed to be reliable, we make no warranties as to the accuracy of the content of this e-mail, and expressly disclaim and accept no liability for how readers may choose to utilize the content of this e-mail.
 
Readers are strongly urged to independently verify all statements made in this advertisement and to perform their own due diligence on this or any other advertised company. You should go as far as to assume all information in our communications is incorrect until you personally verify the information, and again are encouraged to never invest just based on the information contained in our written communications.
 
This report contains forward-looking statements about the featured company within the meaning of the securities laws.


This message was sent to [e-mail] from:
Prepump Stocks | [e-mail] | DamnGoodPennyPicks | 66 Witherspoon Street | Princeton, NJ 08542
Email Marketing by

Michael Sutton